Please wait while the formulary information is being retrieved.
XEPI (ozenoxacin)
- Impetigo
1 % topical cream
- Apply a thin layer to the affected area(s) by topical route 2 times per day for 5 days
Impetigo
- Apply a thin layer to the affected area(s) by topical route 2 times per day
- Apply a thin layer to the affected area(s) by topical route 2 times per day for 5 days
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- None
Severe
Moderate
- No disease contraindications
XEPI (ozenoxacin)
- Impetigo
- None
- None
More Frequent
Severe
Less Severe
- None
- Acne rosacea
- Seborrheic dermatitis
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- None
Less Severe
- None
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Ozenoxacin
Safety and efficacy not established age < 2 months.
- 1 Day – 59 Days
- Safety and efficacy not established age < 2 months.
Ozenoxacin(top)
- Severity Level:
2
- Additional Notes: Systemic absorption not expected after topical application
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Ozenoxacin(top)
Insufficient human data available
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient human data available |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Impetigo | |
| L01 | Impetigo |
| L01.0 | Impetigo |
| L01.00 | Impetigo, unspecified |
| L01.03 | Bullous impetigo |
| L01.09 | Other impetigo |
| L01.1 | Impetiginization of other dermatoses |
| 0-9 | A-Z |
|---|---|
| L01 | Impetigo |
| L01.0 | Impetigo |
| L01.00 | Impetigo, unspecified |
| L01.03 | Bullous impetigo |
| L01.09 | Other impetigo |
| L01.1 | Impetiginization of other dermatoses |
Formulary Reference Tool